Esperion Therapeutics Statistics

Total Valuation

ESPR has a market cap or net worth of $474.85 million. The enterprise value is $599.10 million.

Market Cap	474.85M
Enterprise Value	599.10M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

ESPR has 197.04 million shares outstanding. The number of shares has increased by 78.21% in one year.

Current Share Class	197.04M
Shares Outstanding	197.04M
Shares Change (YoY)	+78.21%
Shares Change (QoQ)	+3.25%
Owned by Insiders (%)	0.71%
Owned by Institutions (%)	66.52%
Float	195.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	13.48
PS Ratio	1.36
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.03
EV / EBITDA	36.32
EV / EBIT	36.41
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.85

Current Ratio	1.85
Quick Ratio	1.28
Debt / Equity	n/a
Debt / EBITDA	15.57
Debt / FCF	n/a
Interest Coverage	0.28

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	3.84%
Return on Capital (ROIC)	101.42%
Revenue Per Employee	$1.23M
Profits Per Employee	-$361,546
Employee Count	240
Asset Turnover	1.10
Inventory Turnover	1.63

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +102.52% in the last 52 weeks. The beta is 0.95, so ESPR's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	+102.52%
50-Day Moving Average	2.00
200-Day Moving Average	2.22
Relative Strength Index (RSI)	60.61
Average Volume (20 Days)	5,197,125

Short Selling Information

The latest short interest is 33.46 million, so 16.98% of the outstanding shares have been sold short.

Short Interest	33.46M
Short Previous Month	35.39M
Short % of Shares Out	16.98%
Short % of Float	17.11%
Short Ratio (days to cover)	10.38

Income Statement

In the last 12 months, ESPR had revenue of $295.45 million and -$86.77 million in losses. Loss per share was -$0.52.

Revenue	295.45M
Gross Profit	188.03M
Operating Income	16.46M
Pretax Income	-98.50M
Net Income	-86.77M
EBITDA	16.50M
EBIT	16.46M
Loss Per Share	-$0.52

Full Income Statement

Balance Sheet

The company has $144.72 million in cash and $268.96 million in debt, giving a net cash position of -$124.25 million or -$0.63 per share.

Cash & Cash Equivalents	144.72M
Total Debt	268.96M
Net Cash	-124.25M
Net Cash Per Share	-$0.63
Equity (Book Value)	-370.21M
Book Value Per Share	-1.89
Working Capital	141.68M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$25.76 million and capital expenditures -$317,000, giving a free cash flow of -$26.08 million.

Operating Cash Flow	-25.76M
Capital Expenditures	-317,000
Free Cash Flow	-26.08M
FCF Per Share	-$0.13

Full Cash Flow Statement

Margins

Gross margin is 63.64%, with operating and profit margins of 5.57% and -29.37%.

Gross Margin	63.64%
Operating Margin	5.57%
Pretax Margin	-29.37%
Profit Margin	-29.37%
EBITDA Margin	5.58%
EBIT Margin	5.57%
FCF Margin	-3.57%

Dividends & Yields

ESPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-78.21%
Shareholder Yield	-78.21%
Earnings Yield	-18.27%
FCF Yield	-5.49%

Analyst Forecast

The average price target for ESPR is $8.17, which is 239.00% higher than the current price. The consensus rating is "Buy".

Price Target	$8.17
Price Target Difference	239.00%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	63.73%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ESPR has an Altman Z-Score of -5.09 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.09
Piotroski F-Score	6